MARKET

CLLS

CLLS

Cellectis
NASDAQ
4.070
+0.090
+2.26%
After Hours: 4.030 -0.04 -0.98% 17:01 05/14 EDT
OPEN
4.120
PREV CLOSE
3.980
HIGH
4.190
LOW
3.930
VOLUME
23.58K
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.327
MARKET CAP
294.42M
P/E (TTM)
-23.8151
1D
5D
1M
3M
1Y
5Y
1D
Cellectis publishes TALE-based epigenetic modulator screening presentation
PUBT · 1d ago
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
TipRanks · 2d ago
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
TipRanks · 2d ago
Cellectis To Present Phase 1 CAR-T Data For Lasme-cel And Eti-cel At EHA 2026, Highlighting Early Safety, Response Signals And Ongoing Pivotal Programs
Benzinga · 2d ago
Cellectis to present Phase 1 BALLI-01 lasme-cel data at EHA 2026
PUBT · 2d ago
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
Barchart · 2d ago
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
TipRanks · 2d ago
Cellectis sees cash runway into 4Q27
TipRanks · 2d ago
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.